Yat Sun Or, Chief Scientific Officer at ENANTA PHARMACEUTICALS INC (ENTA), sold 2,591 shares at $8.06 ($21K) on 2024-12-06, disclosed to the SEC on 2024-12-10.
Seasonal sale ($21k) by Chief Scientific Officer — this insider has traded ENTA in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ENTA | SELL | 2023-03-17 | $1.2M | — | Filing → |
| ENTA | SELL | 2019-03-04 | $2.1M | — | Filing → |
| ENTA | SELL | 2019-02-13 | $6.1M | — | Filing → |